17β-Estradiol upregulates the expression of peroxisome proliferator-activated receptor α and lipid oxidative genes in skeletal muscle

Journal of Molecular Endocrinology

Volumn 31, Issue 1, 2003, Pages 37-45

  Campbell, S E ^a,b   Mehan, K A ^c   Tunstall, R J ^c   Febbraio, M A ^a,d   Cameron Smith, David ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF WATERLOO   (Canada)

^c DEAKIN UNIVERSITY   (Australia)

^d RMIT UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE; ESTRADIOL; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLACEBO; PROGESTERONE; PYRUVATE DEHYDROGENASE; PYRUVATE KINASE; TRANSCRIPTION FACTOR; CELL RECEPTOR; FATTY ACID; ISOPROTEIN; LIPID; PRIMER DNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENETIC CODE; IMMUNOBLOTTING; LIPID OXIDATION; MUSCLE METABOLISM; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARIECTOMY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; RAT STRAIN; SKELETAL MUSCLE; STATISTICAL ANALYSIS; UPREGULATION; ANIMAL; BLOOD; BODY WEIGHT; DRUG EFFECT; GENETICS; LIPID METABOLISM; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BASE SEQUENCE; BODY WEIGHT; DNA PRIMERS; ESTRADIOL; FATTY ACIDS, NONESTERIFIED; FEMALE; GENE EXPRESSION REGULATION; LIPID METABOLISM; LIPIDS; MUSCLE, SKELETAL; OVARIECTOMY; OXIDATION-REDUCTION; PROGESTERONE; PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 0041852780     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0310037     Document Type: Article

References (36)

1. Beckett T, Tchernof A & Toth MJ 2002 Effect of ovariectomy and estradiol replacement on skeletal muscle enzyme activity in female rats. Metabolism 51 1397-1401.
2. Calkhoven CF, Snippe L & Ab G 1997 Differential stimulation by CCAAT/enhancer-binding protein alpha isoforms of the estrogen-activated promoter of the very-low-density apolipoprotein II gene. European Journal of Biochemistry 249 113-120.
3. Camirand A, Marie V, Rabelo R & Silva JE 1998 Thiazolidinediones stimulate uncoupling protein-2 expression in cell lines representing white and brown adipose tissues and skeletal muscle. Endocrinology 139 428-431.
4. Campbell SE & Febbraio MA 2001a Effects of ovarian hormones on exercise metabolism. Current Opinion in Clinical Nutrition and Metabolic Care 4 515-520.
5. Campbell SE & Febbraio MA 2001b Effect of ovarian hormones on mitochondrial enzyme activity in the fat oxidation pathway of skeletal muscle. American Journal of Physiology Endocrinology and Metabolism 281 E803-E808.
6. Chomezynski P & Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162 156-159.
7. Djouadi F, Weinheimer CJ, Saffitz JE, Pitchford C, Bastin J, Gonzalez FJ & Kelly DP 1998 A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor alpha-deficient mice. Journal of Clinical Investigation 102 1083-1091.
8. Gargett CE, Zaitseva M, Bucak K, Chu S, Fuller PJ & Rogers PAW 2002 17β-Estradiol up-regulates vascular endothelial growth factor receptor-2 expression in human myometrial microvascular endothelial cells: role of estrogen receptor-α and -β. Journal of Clinical Endocrinology and Metabolism 87 4341-4349.
9. Gower BA, Nagy TR, Blaylock ML, Wang C & Nyman L 2002 Estradiol may limit lipid oxidation via Cpl 1 expression and hormonal mechanisms. Obesity Research 10 167-172.
10. Gulick T, Cresci S, Caira T, Moore DD & Kelly DP 1994 The peroxisome proliferator-activated receptor regulates microchondrial fatty acid oxidative enzyme gene expression. PNAS 91 11012-11016.
11. Hamm JK, Park BH & Farmer SR 2001 A role for C/EBPbeta in regulating peroxisome proliferator-activated receptor gamma activity during adipogenesis in 3T3-L1 preadipocytes. Journal of Biological Chemistry 276 18464-18471.
12. Hirotani M, Tsukamoto T, Bourdeaux J, Sadano H & Osumi T 2001 Stabilization of peroxisome proliferator-activated receptor alpha by the ligand. Biochemical and Biophysical Research Communications 288 106-110.
13. Holness MJ, Bulmer K, Gibbons GF & Sugden MC 2002a Up-regulation of pyruvate dehydrogenase kinase isoform 4 (PDK4) protein expression in oxidative skeletal muscle does not require the obligatory participation of peroxisome-proliferator-activated receptor α (PPARα). Biochemical Journal 366 839-846.
14. Holness MJ, Smith ND, Bulmer K, Hopkins T, Gibbons GF & Sugden MC 2002b Evaluation of the role of the role of peroxisome-proliferator receptor alpha in the regulation of cardiac pyruvate dehydrogenase kinase 4 protein expression in response to starvation, high-fat feeding and hyperthyroidism. Biochemical Journal 364 687-694.
15. Katzenellenbogen JA, Mathias CJ, VanBrocklin HF, Brodack JW & Welch MJ 1993 Titration of the in vivo uptake of 16 alpha-[18F] fluoroestradiol by target tissues in the rat: competition by tamoxifen, and implications for quantitating estrogen receptors in vivo and the use of animal models in receptor-binding radiopharmaceutical development. Nuclear Medicine and Biology 20 735-745.
16. Lemberger T, Staels B, Saladin R, Desvergne B, Auwerx J & Wahli W 1994 Regulation of the peroxisome proliferator-activated receptor alpha gene by glucocorticoids. Journal of Biological Chemistry 269 24527-24530.
17. Lemberger T, Braissant O, Juge-Aubry C, Keller H, Saladin R, Staels B, Auwerx J, Burger AG, Meier CA & Wahli W 1996 PPAR tissue distribution and interactions with other hormone-signaling pathways. Annals of the New York Academy of Sciences 804 231-251.
18. Loviscach M, Rehman N, Carter L, Mudaliar S, Mohadeen P, Ciaraldi TP, Veerkamp JH & Henry RR 2000 Distribution of peroxisome proliferation-activated receptors (PPARS) in human skeletal muscle and adipose tissue: relation to insulin action. Diabetologia 43 304-311.
19. Ma H, Spreeher HW & Kolattukudy PE 1998 Estrogen-induced production of peroxisome proliferator-activated receptor (PPAR) ligan in a PPARgamma-expressing tissue. Journal of Biological Chemistry 273 30131-30138.
20. Majer M, Popov KM, Harris RA, Bogardus C & Prochazka M 1998 Insulin downregulates pyruvate dehydrogenase kinase (PDK) mRNA: potential mechanism contributing to increased lipid oxidation in insulin-resistant subjects. Molecular Genetics and Metabolism 65 181-186.
21. Mascaro C, Acosta E, Ortiz JA, Marrero PF, Hegardt FG & Haro D 1998 Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor. Journal of Biological Chemistry 273 8560-8563.
22. Minnich A, Tian N, Byan L & Bilder G 2001 A potent PPARalpha agonist stimulates mitochondrial fatty acid beta-oxidation in liver and skeletal muscle. American Journal of Physiology (Endocrinology and Metabolism) 280 E270-E279.
23. Muoio DM, MacLean PS, Lang DB, Li S, Houmard JA, Way JM, Winegar DA, Corton JC, Dohm GL & Kraus WE 2002a Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscle of peroxisome proliferator-activated receptor (PPAR) α knock-out mice. Journal of Biological Chemistry 277 26089-26097.
24. Muoio DM, Way JM, Tanner CJ, Winegar DA, Kliewer SA, Houmard JA, Kraus WE & Dohm GL 2002b Peroxisome proliferation-activated receptor-alpha regulates fatty acid utilization in primary human skeletal muscle cells. Diabetes 51 901-909.
25. Nemoto Y, Toda K, Ono M, Fujikawa-Adachi K, Saibara T, Onishi S, Enzan H, Okada T & Shizuta Y 2000 Altered expression of fatty-acid metabolizing enzymes in aromatase-deficient mice. Journal of Clinical Investigation 105 1819-1825.
26. Orphanides G & Reinberg D 2002 A unified theory of gene expression. Cell 108 439-451.
27. Rosa G, Di Rocco P, Manco M, Greco AV, Castagneto M, Vidal H & Mingrone G 2003 Reduced PDK4 expression associates with increased insulin sensitivity in post-obese patients. Obesity Research 11 176-182.
28. Serova L, Rivkin M, Nakashima A & Sabban EL 2002 Estradiol stimulates gene expression of norepinephrine biosynthetic enzymes in rat locus coeruleus. Neuroendocrinology 75 193-200.
29. 125I] progestin. Endocrinology 123 2382-2389.
30. Steineger HH, Sorensen HN, Tugwood JD, Skrede S, Spydevold O & Gautvik KM 1994 Dexamethasone and insulin demonstrate marked and opposite regulation of the steady-state mRNA level of the peroxisomal proliferator-activated receptor (PPAR) in hepatic cells. Hormonal modulation of fatty-acid-induced transcription. European Journal of Biochemistry 225 967-974.
31. Sugden MC & Holness MJ 1994 Interactive rcgulation of the pyruvate dehydrogenase complex and the carnitine palmitoyltransferase system. FASEB Journal 8 54-61.
32. Sugden MC, Kraus A, Harris RA & Holness MJ 2000 Fibre-type specific modification of the activity and regulation of skeletal muscle pyruvate dehydrogenase kinase (PDK) by prolonged starvation and refeeding is associated with targeted regulation of PDK isoenzyme 4 expression. Biochemical Journal 346 651-657.
33. Toda K, Takeda K, Akira S, Saibara T, Okada T, Onishi S & Shizuta Y 2001 Alterations in hepatic expression of fatty-acid metabolizing enzymes in ArKO mice and their reversal by the treatment with 17 beta-estradiol of a peroxisome proliferator. Journal of Steroid Biochemistry and Molecular Biology 79 11-17.
34. Whitley JC, Giraud AS, Mahoney AO, Clarke IJ & Shulkes A 2000 Tissue-specific regulation of gastrin-releasing peptide synthesis, storage and secretion by oestrogen and progesterone. Journal of Endocrinology 166 649-658.
35. Wu P, Inskeep K, Bowker-Kinley MM, Popov KM & Harris RA 1999 Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes. Diabetes 48 1593-1599.
36. Ye JM, Doyle PJ, Iglesias MA, Watson DG, Cooney GJ & Kraegen EW 2001 Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation. Diabetes 50 411-417.